Abstract
Background Soluble suppression of tumorigenicity-2 (sST2) predicts mortality in heart failure patients. The predictive value of sST2 in left ventricular assist device (LVAD) patients remains unknown. Therefore, we studied the relationship between sST2 and outcome after LVAD implantation. Methods Patients implanted between January 2015 and December 2022 were included. Survival
... read more